Showing 25891 - 25900 of 27953 for "Pharmaceuticals and life sciences" with applied filters
30 March 2016 by Joseph Frumkin and Krishna Veeraraghavan
Joseph Frumkin and Krishna Veeraraghavan of Sullivan & Cromwell assess the M&A regulatory framework in the United States
30 March 2016 by Richard Ma and Leo Wang
Richard Ma and Leo Wang of DaHui Lawyers assess the M&A regulatory framework in China
30 March 2016 by Dipankar Bandyopadhyay and Priyanka Devgan
Dipankar Bandyopadhyay and Priyanka Devgan of Verus assess the M&A regulatory framework in India
30 March 2016 by Caroline Williams and Theo Lefkos
Caroline Williams and Theo Lefkos of Walkers assess the M&A regulatory framework in the Cayman Islands
30 March 2016 by Freddy Karyadi and Ayik Candrawulan Gunadi
Freddy Karyadi and Ayik Candrawulan Gunadi of Ali Budiardjo Nugroho Reksodiputro assess the M&A regulatory framework in Indonesia
30 March 2016 by Kazi Ershadul Alam and Imran Anwar
Kazi Ershadul Alam and Imran Anwar of Tanjib Alam assess the M&A regulatory framework in Bangladesh
30 March 2016 by Pablo A. Artagaveytia and Barbara V. Ramperti
Pablo A. Artagaveytia and Barbara V. Ramperti of Marval O'Farrell & Mairal assess the M&A regulatory framework in Argentina
30 March 2016 by Mark Anthony Fraser
Mark Anthony Fraser of Frasers Law Company assesses the M&A regulatory framework in Vietnam
30 March 2016 by Paulo Coelho da Rocha
Paulo Coelho da Rocha of Demarest Advogados assesses the M&A regulatory framework in Brazil
30 March 2016 by Cesar Arbe Saldaña
Cesar Arbe Saldaña of Arbe Abogados assesses the M&A regulatory framework in Peru